Overview Financials News + Filings Key Docs Ownership Insiders
|
Rani Therapeutics Holdings, Inc.
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 |
| Source | Source | Source | Source | Source | Source |
Turnover Ratios |
Asset turnover | 0.0 | 0.3 | 0.0 | | | |
|
Returns on Capital |
ROIC (excluding intangibles) | -145.1% | -145.1% | -643.6% | | | |
ROIC (including intangibles) | -81.9% | -81.9% | -517.1% | -517.1% | -273.5% | |
ROE | -85.8% | -85.8% | -42.5% | -42.5% | -23.2% | |
ROA | -58.8% | -58.8% | -41.6% | -41.6% | -20.9% | |
|
Cash Conversion Cycle |
Days sales outstanding | | 0.0 | 0.0 | 0.0 | 0.0 | |
Days payables outstanding | | 8.4 | | 7.3 | | |
Cash conversion cycle | | -8.4 | | -7.3 | | |
|